Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Valcyte*


Contraindicated
Teratogenic

Contraindicated
Valcyte* :
Type Medicine Non Marketed
Originator B
Agent Omnipharma
Distributor Omnipharma
Laboratory Roche
Responsible Party Patheon Inc
Origin Canada
Manufacturer Patheon Inc
Origin Canada
ATC J05AB14

Your comment will appear shortly after approval

Valcyte* :

Revision Date : 01/07/2011


Effect Frequency
Abdominal distension Common
Abdominal pain Very Common
Abdominal pain upper Common
Acne Common
Agitation Uncommon
Anaemia Very Common
Anaphylaxis Not known
Anorexia Common
Aplastic anemia Rare
Arthralgia (Pain joint) (Joint ache) Common
Asthenia Common
Back pain Very Common
Blood creatinine increased Very Common
Bone marrow depression Uncommon
Bronchitis Common
Cachexia Common
Cephalea Very Common
Confusion Uncommon
Constipation Very Common
Convulsion Uncommon
Cough Very Common
Creatinine renal clearance decreased Common
Decreased appetite Common
Dehydration Common
Depression Common
Dermatitis Very Common
Diarrhoea (Diarrhea) Very Common
Drug hypersensitivity Uncommon
Dyspepsia Very Common
Dyspnoea (dyspnea) Very Common
Dysuria (Micturition painful) Common
Fatigue Very Common
Fertility male decreased Not known
Hallucination Uncommon
Hepatic function disorder Common
Hyperglycaemia Common
Hyperkalaemia Very Common
Hypertension Very Common
Hypocalcaemia Common
Hypokalaemia Common
Hypomagnesaemia Common
Hypophosphataemia Common
Hypotension Common
Influenza Common
Insomnia Very Common
Leg oedema Very Common
Leucopenia (Leukopenia) Very Common
Lightheadedness Very Common
Macular oedema Common
Muscle cramps Common
Nasopharyngitis Very Common
Nausea Very Common
Neuropathy peripheral Common
Neutropenia Common
Night sweats Common
Oedema Very Common
Oedema peripheral Common
Oral candidiasis Very Common
Pain Common
Pain in extremity (Pain in limb) Common
Pancytopenia Common
Paraesthesia (paresthesia) Common
Pharyngitis Very Common
Phlebitis Common
Platelet count decreased (Thrombocyte count decreased) Common
Pleural effusion Common
Pneumocystis carinii pneumonia Common
Pneumonia Common
Postoperative complications Very Common
Postoperative pain Very Common
Productive cough Common
Prothrombin level decreased Very rare
Pruritus Common
Psychosis Not known
Pyrexia Very Common
Renal impairment Common
Retinal detachment Common
Rhinorrhoea Common
Sinusitis Common
Thrombocytopenic hemorrhage Common
Thrombophlebitis Common
Transplant rejection Very Common
Tremor Very Common
Upper respiratory tract infection Common
Urinary tract infection Very Common
Vision blurred Common
Vomiting Very Common
Weight decreased (Weight loss) Common
Wound dehiscence Common
Wound infection Very Common

Different Units By MoH Code

Valcyte*  MoH 5053 :
Form Tablet, Film-Coated
Packaging Bottle (HDPE) (high density polyethylene)
Package Size Box of 60
Strength 450mg
NSSF ✘
Quarantine ✘
Reg. Number 241116/06
Submission date 01/01/2006
Registration Year 2006
Archived Date 2014


Price Comparison

● Country: Germany
● Package Size: 60
● Public Price: 2182.68 EUR ( 211,449,307.68 LBP )
● Pack size unit used: 60
● Cost/Unit: 36,378 EUR ( 3,487,536.00 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info